The New Technologies SIG Agenda for Breakfast:
1. Lecture & Discussion: “Induced Pluripotent Stem Cells”. Presenter: Ivan Rich, HemoGenix Inc.
2. Lecture & Discussion: “Omics analysis of archived tissue samples- Recent Advances”- Dr. Les Recio or Colleague, ILS.
3. Election of Co-Chair (Dr. Brinda Mahadevan stepping down)
Dr. Ivan Rich is the CEO of HemoGenix that is involved in developing toxicological applications for iPS cells. He will provide an overview of iPS cells and their potential uses in therapy. Dr. Les Recio will present data relating to technical advances in analyzing archived tissue samples.